Classification of Substrates and Inhibitors of P-Glycoprotein Using Unsupervised Machine Learning Approach-Reference-Cited by-同舟云学术

Classification of Substrates and Inhibitors of P-Glycoprotein Using Unsupervised Machine Learning Approach

Published:2005-04-20 Issue:3 Volume:45 Page:750-757
ISSN:1549-9596
Container-title:Journal of Chemical Information and Modeling
language:en
Short-container-title:J. Chem. Inf. Model.

Author:

Wang Yong-Hua¹,Li Yan¹,Yang Sheng-Li¹,Yang Ling¹

Affiliation:

1. Lab of Pharmaceutical Resource Discovery, Dalian Institute of Chemical Physics, Graduate School of the Chinese Academy of Sciences, #457 Zhongshan Road, Dalian 116023, China, and School of Chemical Engineering, Dalian University of Technology, #158 Zhongshan Road, Dalian 116012, China

Publisher

American Chemical Society (ACS)

Subject

Library and Information Sciences,Computer Science Applications,General Chemical Engineering,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/ci050041k

Reference20 articles.

1. P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement

Cited by 123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Role for iNOS in Erastin Mediated Reduction of P-Glycoprotein Transport Activity;Cancers;2024-04-29

2. The Tetrahydroisoquinoline Scaffold in ABC Transporter Inhibitors that Act as Multidrug Resistance (MDR) Reversers;Current Topics in Medicinal Chemistry;2022-12

3. Identification of novel bioactive compounds from Olea europaea by evaluation of chemical compounds in the OliveNet™ library: in silico bioactivity and molecular modelling, and in vitro validation of hERG activity;Computers in Biology and Medicine;2022-03

4. Introduction to the BioChemical Library (BCL): An Application-Based Open-Source Toolkit for Integrated Cheminformatics and Machine Learning in Computer-Aided Drug Discovery;Frontiers in Pharmacology;2022-02-21

5. Emerging nanotechnology based combination therapies of taxanes for multiple drug-resistant cancers;Pharmaceutical Development and Technology;2021-12-05